Stratrix
On the Record · Endo

Endo competitors, on the record

The companies Endo itself names as competitors in its annual reports, 2024, each with the sentence it appears in and the filing it came from.

Who Endo names

CompanyNamed in
Amgen, Inc.2024
Amneal Pharmaceuticals, Inc.2024
Amphastar Pharmaceuticals, Inc.2024
Aurobindo Pharma Limited2024
Fresenius Kabi USA, LLC2024
Hikma Pharmaceuticals PLC2024
Jazz Pharmaceuticals plc2024
Pfizer Hospital US2024
Sandoz Group AG2024
Takeda Pharmaceutical Company Limited2024
Teva Pharmaceutical Industries Limited2024
Viatris Inc.2024

In its own words

  1. Amgen, Inc., Jazz Pharmaceuticals plc, Takeda Pharmaceutical Company Limited, Viatris Inc.

    Word for word“This segment’s major competitors, including Viatris Inc. (Viatris), Jazz Pharmaceuticals plc (Jazz), Takeda Pharmaceutical Company Limited and Amgen, Inc., among others, vary depending on therapeutic and product category, dosage strength and drug-delivery systems, among other factors.” 10-K for 2024
  2. Amneal Pharmaceuticals, Inc., Amphastar Pharmaceuticals, Inc., Fresenius Kabi USA, LLC, Hikma Pharmaceuticals PLC, Pfizer Hospital US, Sandoz Group AG

    Word for word“Sterile Injectables This segment’s major competitors, including Pfizer Hospital US, Fresenius Kabi USA, LLC, Viatris, Amphastar Pharmaceuticals, Inc., Amneal Pharmaceuticals, Inc. (Amneal), Hikma Pharmaceuticals PLC and Sandoz Group AG (Sandoz), among others, vary by product.” 10-K for 2024
  3. Aurobindo Pharma Limited, Teva Pharmaceutical Industries Limited

    Word for word“Our major competitors, including Teva Pharmaceutical Industries Limited, Viatris, Sandoz, Aurobindo Pharma Limited and Amneal, among others, vary by product.” 10-K for 2024

Read from Endo’s annual reports (10-K for 2024) and the financial data it files with the SEC, as of 2025-03-13. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.